Sara Jean Buhrlage

2 Patents

• US125645912026

  HCK as a Therapeutic Target in MYD88 Mutated Diseases

  Dana-farber Cancer Institute, Inc.

  0 cites
• USRE0500302024

  Methods to Treat Lymphoplasmacytic Lymphoma

  Dana-farber Cancer Institute, Inc.

  0 cites